Magnolol as STAT3 inhibitor for treating multiple sclerosis by restricting Th17 cells
Jianyu Chen, Xiao-Yun Tian, Shan-Shan Wei, Wen Xu, Rongrong Pan, Lin-Lin Chen, Lang-Dong Chen, Lihong Nan, Yao Lin, Shan-Deng, Qianqian Wang, Xueqin Ma, Mingqing Huang
Topics & Concepts
MagnololExperimental autoimmune encephalomyelitisIn vivoPharmacologySTAT3RAR-related orphan receptor gammaInterleukin 17ChemistryMultiple sclerosisImmunologyCytokineImmune systemMedicineBiologySignal transductionFOXP3BiochemistryBiotechnologyMagnolia and Illicium researchNeuroinflammation and Neurodegeneration MechanismsNuclear Receptors and Signaling